SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " View " 13,118 found 🔀 AI-powered Shuffle
Ornithologist John Weske devoted life to shorebird science
John S. Weske, whose long-term banding of royal terns and brown pelicans contributed to current understanding, died Oct. 18 at 90.
West Greene Insurance & Tax Service joins GCP
Click here to view this article from greenevillesun.com.
Community members speak out during tense mental health advisory board meeting
Community members impacted by the withdrawal of Kings View services shared concerns during a mental health advisory board meeting last week, saying the closure of a local mental health center had left gaps in care. Board members also navigated a number of other tense moments during the meeting.
Earnings to watch: Caesars Entertainment (CZR) reports Q3 results tomorrow
Hotel and casino entertainment company Caesars Entertainment NASDAQ:CZRwill be reporting earnings this Tuesday after market close. Here’s what to expect.Caesars Entertainment beat analysts’ revenue expectations last quarter, reporting revenues of $2.99 billion, up 3% year on year. It was a softer q…
Il Volo celebrates nearly 20 years of musical harmony
Longer than many marriages and most rock bands, the Italian singing trio Il Volo have been together for almost 20 years. They’ve gone from teenagers to 30-somethings while selling more
Windows 11’s new “better performance” toggle shows up, but your current PC will never be able to use it
Windows 11's recent preview builds include a new toggle called "Advanced Performance Extensions," aka "APX," and on supported hardware.
Wizards at Hornets Preview: Washington heads south to Charlotte
Wizards head to Charlotte for their first matchup against the Charlotte Hornets this season.
Preparing for what’s next: Nursing insights on Future Ready Healthcare
New 2026 survey findings reveal how nurses view workforce sustainability, AI adoption, and patient communication, offering practical insights into what it takes to build a future-ready healthcare organization.
Phantom Blade Zero review: dark wuxia martial arts masters with an apprentice's execution
S-Game's Unreal Engine 5 'kungfupunk' debut can't help but get tangled in frustrating design choices.
Probi and Symrise spotlight new clinical evidence at SupplySide Global
At SupplySide Global 2026, Symrise and Probi present new clinical findings for skin radiance and digestive health alongside a stable probiotic designed to broaden formulation options for brands
Med Center Health Heroes Fest a huge success
Email newsletter signup Polls What is the biggest challenge facing Bowling Green? Vote Now View Results
Democrat Coumba Kebe wants to keep the politics out of the treasurer’s office
Political newcomer Coumba Kebe is the Democratic nominee for Indiana state treasurer. Kebe wants to keep the politics out of the office and build back trust with people.
'The Furious': Best-Reviewed Action Movie of 2026 Now Available to Stream
USC Drops Out of AP Top 25 Poll After Wisconsin Loss, UCLA Rises Again
Both the USC Trojans and the UCLA Bruins had their rankings in the Associated Press Top 25 poll following their results from Saturday. View this post on Instagram A post shared by LA Sports Report (@lasportsreport) What Happened to USC’s Ranking? Following their loss to Wisconsin on Saturday, USC dropped out of the Top 25. […] The post USC Drops Out of AP Top 25 Poll After Wisconsin Loss, UCLA Rises Again appeared first on LA Sports Report.
Heidi Klum frightens fans, teases Halloween costume with bizarre close-up of strange prosthetic
The Queen of Halloween herself Heidi Klum is offering fans a first look at this year’s Halloween costume. As usual, it involves some pretty bizarre prosthetics.
Blanche defends DOJ lawsuit blocking Alaska Senate results if Republican loses
Attorney General Todd Blanche defended the Justice Department's suit over Alaska's Senate race in an interview on CNN.
BCM hosting special Nov. 13 show for America 250
BRISTOL — In partnership with The Crooked Road: Virginia’s Heritage Music Trail, Mountain Empire Children’s Choral Academy, and Theatre Bristol, the Birthplace of Country Music Museum is bringing together an
‘You Can See Everything’ surges with $19.5M at box office; ‘Clayface’ takes No. 1
DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday.
'You Can See Everything' surges with $19.5M at box office; 'Clayface' takes No. 1
DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday | KCBS All News 106.9FM and 740AM
'You Can See Everything' surges with $19.5M at box office; 'Clayface' takes No. 1
DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday | KNSS Radio
'You Can See Everything' surges with $19.5M at box office; 'Clayface' takes No. 1
DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday | KMBZ
'You Can See Everything' Surges With $19.5M at Box Office; 'Clayface' Takes No. 1
NEW YORK (AP) — DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday. But the biggest success story in theaters remained A24’s Elizabeth Holmes documentary “You Can See Everything,” which pulled in $19.5 million in its ...
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
Jennifer Hawks explains why she should be California's State Treasurer
Jennifer Hawks, a candidate for California state treasurer, shared her qualifications and vision for the office in an interview on California Politics 360.
Who can buy California's voter rolls and why?
Chris Micheli, an adjunct professor at McGeorge School of Law and longtime lobbyist, explained who is able to buy the voter rolls and why in an interview on California Politics 360.
South Texas Health System (@stxhealthsystem)
1 likes, 1 comments - stxhealthsystem on October 25, 2026: "Exceptional Care Starts With You: Nurses play a vital role in every patient journey, providing the compassionate, skilled care that helps make South Texas Health System’s 12 facilities a trusted healthcare resource for communities across the Rio Grande Valley. If you're passionate about making a difference and delivering exceptional patient care, now is your opportunity to join the largest integrated healthcare network in the region. STHS is seeking dedicated and compassionate registered nurses to join its team at four acute care hospitals, a behavioral health hospital and seven freestanding emergency departments. Become part of a team committed to clinical excellence, collaboration and compassionate care. To view current openings and apply, visit the STHS careers page at the link in our bio.".
Preview
The Men's First Team are back in Serie A action, this time heading south to face Lecce in Puglia.The Serie A Matchday 8 clash is set to take place at the Stadio Via del Mare at 18:00 CET on Sunday, Oc...
Roots music fest fun in downtown Yadkinville
Click here to view this article from yadkinripple.com.
Stop Chasing Views: How 87% of Creators Are Using AI to Build Real Businesses Beyond Social Media
87% of creators say AI is growing their business. Here's how creators trade social media algorithms for owned commerce and real enterprises.
Adam Schiff responds to DOJ’s Alaska threat: ‘it’s Alaska’s business’ to run elections
In an exclusive interview with Meet the Press, Sen. Adam Schiff (D-Calif.) says “it's not the federal government's business to run Alaskan elections,” after the Justice Department sued to block certification of Alaska’s election results if Sen. Dan Sullivan loses, due to another candidate with the same name appearing on the ballot.
Tickets on sale now for 49 Winchester's Charlottesville show next year
49 Winchester, a homegrown Virginia country rock band, is the first band announced for Ting Pavilion's 2027 lineup. Tickets are on sale now.
Clay Walker Christmas coming to NPAC Nov. 29
GREENEVILLE — Rumor has it … it’s shaping up to be A Clay Walker Family Christmas.
Political analysis favors Mendoza over Ciscomani
The Cook Political Report has switched its assessment of the congressional race for the House seat from a “toss-up” ranking to “Leans Democratic.”
Business Ins and Outs | Atlanta dessert shop, Provisions, Mexirican and donut shop opening
Business Ins and Outs | Atlanta dessert shop, Provisions, Mexirican and donut shop opening
The Health Benefits of Blueberries—and the Best Ways to Eat Them
Are blueberries good for you? Experts share the health benefits of these popular berries. Plus, discover what to look for when buying blueberries, the best way to store them, and how to use blueberries in your food and cooking.
Review: 'Whalefall' a big fish tale thriller within a fraught father/son relationship
Movie reviewer Joshua Hill says 'Whalefall' combines a fraught father/son relationship with a suspenseful narrative featuring excellent sound design and imagery.
Longview summit to bring together mental health, substance abuse treatment providers - Longview News-Journal
The East Texas Council on Alcoholism and Drug Abuse will bring together mental health experts, substance abuse treatment providers and more during a Nov. 4 conference in Longview. The East […]
Udinese vs AC Milan – Match preview and team news
AC Milan will aim to get inside the top four of the Serie A league table by securing all three points when they meet Udinese on Sunday away from home in their next match.Udinese vs AC Milan – Match...
Outside View: Sensible steps on health care caused uproar. Now the numbers are in
By Washington Post Editorial Board
Why scientists no longer think plastic is the safest material around
For decades, scientists believed that plastics were some of the safest materials around. Now it's clear how flawed that view was.
VT Science Corner: Expanding eating disorder care to rural areas
The great Taylor Swift proclaimed “I’m the problem, it’s me” in her 2022 song, "Anti-Hero." This lyric reflects something many people can recognize: the belief that something is fundamentally wrong
Hibernian vs Celtic – Match preview and team news
Celtic will look to bounce back from their recent European defeat as they travel away from home to face Hibernian in their next Scottish Premiership match on Sunday.Hibernian vs Celtic – Match prev...
Science Hill lost in the TSSAA state volleyball finals on Friday
Franklin's win capped a banner day for Nashville-area Division I programs as they teams swept the Class A (Eagleville), AA (Valor Prep) and AAA championships.
Barcelona vs Real Madrid, La Liga: Preview
The biggest game in the game, with a whole lot at stake
Ramaswamy ad puts Acton’s estranged mother in spotlight as records reveal family’s troubled past
Vivek Ramaswamy faces bipartisan backlash over an ad featuring Amy Acton’s estranged mother, whose rocky history emerges in court records and interviews.
Sunday Preview – Orlocks rule the roads of Necromunda
See what’s coming up next week for Necromunda, Warhammer 40,000, and more.
‘Optimus Prime: Awakening’ review: Peter Cullen delivers an emotional performance | Texas A&M University-San Antonio
“Optimus Prime: Awakening” is a 12-minute short film that was screened alongside the 40th anniversary theatrical re-release of “The Transformers: The Movie.” Released in 1986 after the first two seasons of the animated series, “The Transformers: The Movie” returned to theaters in 2026 as part of Hasbro’s yearlong “Apology Tour.” The marketing campaign celebrated the...
On Invoking History
Bruno Fernandes’ post-match interview after the humiliating loss to Como took aim at many things, including the tendency to analyse the club’s present in relation to its past. Fernandes wasn’t disrespecting it but suggesting that these are very different times. Just a week earlier, Lisandro Martinez stated that we don’t have to go that far […]
Netflix’s Leadership Shake Up…Explained
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Well, I had a simple article planned for this week. Called “Whoa, I Missed It!”, I’d take a gander at a few important-but-under-the-radar stories I didn’t cover while I wrote about all things “Skydance. (Formerly known as “the saga of Netflix trying to buy Warner Bros., but not Discovery, then Paramount-Skydance bought all of Warner Bros. Discovery”.) Alas, that article will have to wait. Netflix made news. Ironically, my “Whoa, I Missed It!” article would have mostly been about “content” strategy decisions, which is also what today’s article is about. But instead of the entire industry, this article will only cover Netflix’s decision to upend their film and TV content teams. Just that! So that’s the full topic of the day. I’m going to tackle the issue in the opposite direction of the way “stuff” flows: uphill. We’ll start at film, then move onto TV, and then onto the CEOs themselves, and the strategy questions that still remain. But we start with the numbers driving this. Let’s dive in. Subscribe Most Important Story of the Week - Netflix Upends Their Corporate Hierarchy I’ve got a lot of thoughts, but we’ll start with the most common response to yesterday’s article. Let’s Talk Stock Price More than one person, responding to what I published two days ago, pointed out that, well, actually, the thing driving Netflix’s actions is this: In short, stock price! Even if Netflix isn’t obsessed with their own share price—they probably are, but, for the record, my strategic advice to every CEO is to absolutely ignore stock prices, which will, ironically, probably help the stock price long-term—most everyone thinks they are. By the way, I prefer market capitalization to stock prices, because it’s a more apples-to-apples way to compare companies: But there’s an even better way to look at it, and it kinda casts some doubt on the entire push here: price-to-earnings. I have a long list of articles that I wish I had written, and chief among them is an article titled, “Am I Still a Netflix ‘Bear’?” meaning someone who thinks Netflix’s stock is overvalued. As of last summer, Netflix had solved their biggest problem—which for me (circa 2019) was the lack of free cash flow—but their stock was CRAZY overvalued. That’s this chart here: Why did Netflix’s stock price increase to a price-to-earnings ratio of 50 last summer? What financial metric changed so quickly? Nothing. Given that, historically, mature entertainment companies average 10 to 20, with 16 being the average, that increase made little sense. Netflix’s stock swoon these last eight or so months wasn’t irrational; the stock price rise last year was. So if you want a really hot Netflix take, here it is: Netflix’s stock price has been going down because the financial industry recovered its senses, not because of any strategic mistake. Yes, that would imply that cleaning house may have been a mistake. That’s why the charts yesterday are so important, because they show that Netflix did have a strategic problem (a lack of hits) and that’s what they moved to address. (One could also argue the industry drastically overrated Netflix’s growth prospects, but that’s a financial industry problem, not a Netflix strategy problem per se. Some growth estimates are just crazy. *cough* AI *cough*) Now, the last time Netflix’s stock price crashed—circa 2022—it gave them an opening. I’d argue Netflix insiders knew they needed to expand post-COVID-19 crisis, adding advertising, cracking down on password sharing, and dabbling in sports. But if they had done that when their stock price was high, it would give folks a reason to second guess their strategy. (Arguably, last year, when Netflix pursued the Warner Bros. merger, it gave the industry a chance to review their business.) Instead, after the 2022 fall, they had the opening to make strategic changes. We may see Netflix pivot again following this latest slide. For example, the “binge versus weekly” conversation is alive and well again. Same for expanding into theaters even more. And adding both linear channels and streaming bundles. And maybe more either social, user-generated, vertical, or creator content. But the first shift came with who is making the content calls. A Message from Our Sponsor Last winter Pulp Fiction was on Netflix. For those same 90 days, it was also free, with ads, on Pluto TV and the Roku Channel. That is not a glitch, and it is not rare. The title has run on 20 different US streaming services since 2019, across 80 separate windows, and for more than 600 of those days it sat on a paid subscription service and a free ad-supported one at the same time. Almost nobody can see this, because when a title leaves a service, the record that it was ever there tends to leave with it. Reelgood keeps that record, dated to the day rather than the month: 4MM+ movie, show and episode titles across 300+ services globally, with timestamped arrivals, departures and moves across SVOD, AVOD, TVOD and vMVPD. Licensing teams price against every prior window. Rights teams check what a licensee actually delivered, and when. Pick a title you think you know: data.reelgood.com/title-availability Film - Dan Lin Want to know why I don’t opine on individual film or TV executives, especially new hires? Dan Lin. As I always caution, it’s really, really, really tough to predict which executives will succeed in new roles and which won’t. The successful head of co-production/finance partner, Rideback, Lin was considered for the head of DC Studios job before taking the job as the head of Netflix. By all accounts at the time, this was a smart hire. (That’s my read of the news coverage anyways.) But now that Netflix has fired Dan Lin, we got a slew of news stories about how he was doing a terrible job. In sports media, Bryan Curtis, new Substack writer/podcaster from The Ringer, calls this the “now you tell us” story, when you only hear the bad news after a star athlete leaves a sports team. In this case, now they tell us that Dan Lin was bad with talent after he got kicked out the door. So was Dan Lin a flop? It’s actually tough to say. While film moves faster than TV, even two years isn’t really enough time to evaluate a person’s output. The new head hasn’t really taken control. As Emily Horgan noted, it takes much longer than two years to produce animated films, so yeah, it’s definitely too early to judge in that domain. As for live-action films, I just published an article by Brandon Katz called “Netflix’s Summer of Bummer”, but I’d point out Netflix had a bad summer two years ago too. Arguably, their best summer came from KPop Demon Hunters last year and Happy Gilmore 2, the latter of which I saw credited to Lin. Then, the stories came out that Dan Lin clashed with talent, both Ben Affleck and Greta Gerwig, classic “now they tell us” factoids to explain his firing. This may have been true, but also should have been expected given that he was given the mandate to bring budgets back in check, especially after Rebel Moon. So if he made folks upset, well, that’s what he was hired to do! But also, he was described as “well-liked” at his hiring! In that case, I’m a bit sympathetic to Lin, since he may have been undercut by senior leadership, as often happens. Basically, a CEO hires a subordinate to be their “bad cop” and keep budgets in check, but then when talent complains, the CEO ends up undercutting them. That’s how I think you end up with a Narnia movie as expensive as any of the other flops, along with a film executive the town no longer likes. As a result, I think that Netflix is now executing a classic “hire the opposite” move by hiring Peter Rice. This phrase comes from my experience following football and basketball coaching decisions, where teams generally hire the opposite of who they just had. If you have an offense-minded head coach, hire the defensive guy. Or in college football, if you have a strong recruiter, then you pivot to an “X’s and Os” type of guy. Or in pro basketball, if you have a very analytically minded coach, you hire the player-friendly guy. I see that here. After dropping Scott Stuber—arguably a talent-friendly executive with lax budget control—Netflix hired the business guy to keep costs in check. Now Netflix is pivoting back to Peter Rice and presumably a more talent-friendly regime. (Disney, by the way, has done this twice: hiring business guys to succeed talent-friendly Bob Iger. It didn’t work out last time.) When it comes to Peter Rice…we’ll see! Maybe he works out, but maybe he doesn’t. I’d actually say the biggest problem is that Netflix still hasn’t solved its “IP Problem”, in that they don’t own much IP, so they just have a lower hit rate. The new executive won’t solve that. (Though buying Lionsgate would help.) Share “Content” - Bela Bajaria I almost published yesterday’s article after this column, but ended up flipping the order, because it told the story so well. So if you want the data for why Netflix is looking at TV to fix their problems, it’s in that article, this graph in particular: I know I just wrote that it’s often hard to judge executives, but Bajaria ran TV for six years and film for three and a half more. That’s more than enough to judge hit rates, and Netflix needs more hits. That’s the story. Since 2023, Netflix hasn’t had as many hit shows as it used to, and many of its previous power house TV shows have ended their runs (Stranger Things most of all). Also, many shows from 2020 to 2022 probably pre-dated Bajaria’s tenure. (That said, one thing may have been outside of Bajaria’s control, which I explain below.) Let’s lump some content strategy thoughts about Netflix and TV into one place: We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… Why I partially blame Squid Game for Netflix’s latest troubles… What is “the football trap”... Why it might not be the TV shows or films’ fault at all… What change I don’t think Netflix will make... How Bela Bajaria evolved Netflix’s TV strategy in smart ways… Whose departure likely submarined Bajaria’s final few years… One sneaky explanation for Netflix’s content struggles... And a whole lot more... ...please subscribe! We can only keep doing this great work with your support.
South Bend teen’s slime business racks up 21,500 followers and 6.1M views in 23 days
A 14-year-old South Bend-area entrepreneur has gained more than 21,500 Facebook followers and 6.1 million video views in just 23 days with her slime and squishy
Inside Texas Politics | Full Interview with Dallas Police Association President Sean Pease
What is it like being a business neighbor to Foy’s Halloween Store? Here’s what some of them said
Editor’s note: This article originally published in October 2025.
Washington Nationals Player Report: Jorbit Vivas
Taking a look at the latest player review with infielder Jorbit Vivas navigating through an up-and-down 2026 season with the Washington Nationals
AI tool REA cracks paid software: Is the software industry's business model coming to an end?
Videos with titles like “Clone Everything” and “How to Copy Any App” are currently drawing viewers in on YouTube. The open-source tool REA (Reverse Engineer Anything) is designed to analyze the code of any paid app, allowing AI to recreate the software from scratch. Could this disrupt the market? Here's a closer look.
Connie Britton's New Hulu Thriller 'Phony': Finally a Mystery We Won't Solve Right Away
There are a lot of great TV shows out right now. One of them happens to be the new Hulu show everyone is talking about 'Phony' starring Connie Britton and Sam Nivola. Here, my honest review of 'Phony' on Hulu.
How Alzheimer’s and dementia patients teach Wisconsin’s next generation of health care workers
What can someone living with Alzheimer's teach a future doctor or nurse? Quite a lot, it turns out. A unique Wisconsin program pairs UW-Madison students with people in the early stages of Alzheimer's and dementia, turning everyday conversations and outings into lessons no textbook can teach. The friendships are changing how future health care workers understand dementia, while challenging some deeply held misconceptions about what life after a diagnosis really looks like.
2026-27 Season Preview: Ruben Dominguez
The Spanish sharpshooter will provide Xavier a lethal perimeter threat.
Bills news: Previewing potential trade targets and positional needs
Brandon Beane has a few holes to shore up at the trade deadline, including safety, cornerback and inside linebacker.
C.E.O.s Say the A.I. Rollout Is Going Well. Employees Feel Differently.
Surveys show workers and executives have different views on A.I.
'Nobody Wants This' Season 3: a Review, a Prediction and a Public Service Announcement
'Nobody Wants This' season three on Netflix is officially here, and Kristen Bell and Adam Brody are wasting no time jumping into the action. Here, my honest review of 'Nobody Wants This' seasons three and whether it's a must-watch or a must-skip.
Engadget review recap: iPhone Duo, Rivian R2 and more
A roundup of recent reviews from Engadget.
Sixers vs. Bucks preview: How to watch, lineups, broadcast info
The Philadelphia 76ers will play host to the Milwaukee Bucks on Saturday to begin a back-to-back.
INTERVIEW | England call-up Charlie Cresswell’s ‘biggest dream’
Charlie Cresswell (24) has said that earning a call-up to England’s senior team is his “biggest dream”. The Stade Rennais defender had been a regular for the Three Lions at U21 level, but has ye...
Huntington leaders hope to draw visitors in with $1M Thomas Dambo troll
Plans are in the works for the upcoming installation of a Thomas Dambo troll in Huntington, an outdoor art project bringing economic opportunities to the area.
What will author Jeff Kinney’s Cedar Rapids show be like?
“Readers and families can expect the unexpected,” the “Diary of a Wimpy Kid” author told The Gazette. “This will be nothing like any other event they've been to before.”
Preview: Bruins look to stay on pace against Sharks
Just the facts Know your enemy Game notes The Sharks come to Boston on a two-game wining streak. They picked up a win Thursday night, beating the Ottawa Senators 6-2. Tonight’s game ends a six-game road trip for the Sharks where they are 3-1-1. It’s a fairly quick turnaround as the Bruins and Sharks will […]
Cleveland Browns news: Titans preview, trade babble, and more!
The latest Cleveland Browns news and notes from around the NFL in the October 24 edition of the Saturday Dawg Chow.
Warning: This review will make you want a wagon
Wagons have fallen out of favor in the US. Subaru has kept them alive — and the new Trailseeker is wickedly fun.
Champaign County Chamber of Commerce names Michelle's Bridal as Small Business of the Year
Chamber President and CEO Laura Weis: "They've managed to remain relevant and successful for more than 40 years while never losing sight of the personal service and community connections that
SC woman used unique methods to learn English; honored with statewide WVDE award
Kateryna Khoroshylova of South Charleston, West Virginia, is a native of Ukraine. She was one of two people honored in September 2026 by the West Virginia Department of Education for Excellence in Student Achievement for English for Speakers of Other Languages.
PSG – Barcelona breaks historic French record
PSG and Barcelona broke records for French viewing figures in their game on Tuesday night.If you enjoy PSG Talk coverage and want to see more of it, add us as a preferred source on Google to make us a...
Newtown Health Fair Educates And Supports Community
On October 10, the 31st Newtown Health Fair was held at Newtown Community Center. Scores of guests attended. Flu shots were provided for those who wanted them by Housatonic Valley Health District, and...
Oregon vs Illinois Prediction: Are the Ducks Back On Track?
After a big win, Oregon is still in the mix for the Big Ten title and the CFP. Illinois can end both with a home win. Here's the CFN preview and prediction.
Ballon d’Or Preview: Odds, prediction, and how to watch
FC Bayern’s Harry Kane is poised to add a new trophy to his growing collection.
Book review: Former resident writes a good dam novel
At 42, West Virginia native Matthew Neill Null is distinguishing himself as a writer with Pulitzer potential.
Television Q&A: How are TV ratings tracked in the age of str...
Nielsen now combines viewer panels with data from millions of TV devices to track audiences across cable and streaming, while a TV Q&A also tackles wildlife-fil...
10/23 Gridiron Glory
PADUCAH, Ky. — Check out the scores and highlights from week 10 of Gridiron Glory below.
‘Avengers: Doomsday’ preview drops during game 1 of MLB World Series
The ‘Avengers: Doomsday’ preview was revealed during the MLB World Series broadcast of game 1.
Mossy Creek Ghost Tours coming up next week
JEFFERSON CITY — Have you ever wondered about the stories and history behind some of the familiar places in Historic Downtown Jefferson City? The Mossy Creek Foundation in Jefferson City
Reno Experience District puts 12 acres up for sale as a pickleball facility moves forward
HSA users can pay for prescriptions, copays and more while building long-term savings
As open enrollment season approaches, consumers reviewing their health insurance options may want to consider a health savings account, or HSA, as a way to save money on health care expenses.
LIVE: Palmetto Sports Team previews the Charlotte Hornets home-opener from The Hive
WATCH: Palmetto Sports’ Carmine Gemei and Caroline Soro LIVE previewing the Charlotte Hornets home-opener against the Hawks from The Hive.
ACLU of Indiana pauses new director’s start date, launches external review
After expressing his worry that incoming Executive Director Nikkita Oliver would fundamentally change how the ACLU of Indiana chooses cases, the organization's former director of philanthropy says he was fired
Is <i>Klara And The Sun</i> Worth Watching? Our Honest Review Of The Critically Panned Film
Exhibit renovations kick off at the Science Museum of Virginia
Big changes are in store for one of the museum's permanent exhibits.
Improving breast cancer treatment; improving prostate cancer diagnosis; listen to your knee pain; plus other stories with Vanderbilt Health sources
WTVF News Channel 5’s “Morningline” program interviewed Denise Garcia, MD, Assistant Professor of Surgery, about new technology that helps surgeons identify cancer during surgery and improve breast cancer treatment. A Men’s Health story about PSA screening for prostate cancer quoted Kelvin Moses, MD, PhD, Professor of Urology. Men’s Health posted a story, “What Your Knee Pain is Trying to Tell You,” that quotes Charles Cox, MD, MPH, Associate Professor of Orthopaedic Surgery. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: WSMV Channel 4 News (importance of flu shots); MedPage Today (mRNA flu shots); WTVF News Channel 5 (19 people sent to hospital after a sickness outbreak at Walmart facility in Lebanon); Prevention (West Nile virus); HuffPost (prevention pill for COVID); and Newsweek (measles cases continue to increase in the U.S.). Becker’s Hospital Review and Nashville Post covered the Vanderbilt Health News story from Rebecca Warren that Chief Communications Officer John Howser is retiring in March 2027, closing out a nearly 40-year career at Vanderbilt. A Healio story on research about OCT-A biomarkers and diabetic retinopathy quotes Vanderbilt University School of Medicine student Rachel Liu. WPLN Nashville Public Radio quoted Amanda Mixon, MD, MPH, Associate Professor of Medicine, in a story about adverse drug interactions.
WATCH: NFIB warns of small business exodus unless voters repeal income tax
(The Center Square) - The National Federation for Independent Business is sounding the alarm about impacts on small businesses in Washington if the recently passed income tax remains in place.
City finds targeted Kercheval businesses are in compliance
A review of licensing and zoning requirements was requested by a Detroit City Council member.
Google Health 5.11 rolling out expanded 100+ activity detection to Fitbit Air, Pixel Watch
Google Health previewed improved automatic activity tracking, and it’s now beginning to roll out with version 5.11 of the app.
Google Health 5.11 rolling out expanded 100+ activity detection to Fitbit Air, Pixel Watch
Google Health previewed improved automatic activity tracking, and it’s now beginning to roll out with version 5.11 of the app.